Helmut Plett

Pankow, BE 13187, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Pelvic Exenteration: An Ultimate Option in Advanced Gynecological Malignancies-A Single Center Experience.

Pelvic Exenteration: An Ultimate Option in Advanced Gynecological Malignancies-A Single Center Experience.

Journal: Cancers

Published: June 03, 2025

Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study).

Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study).

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 27, 2025

Role of V-Y flap reconstruction in vulvar cancer patients: multicenter retrospective study.

Role of V-Y flap reconstruction in vulvar cancer patients: multicenter retrospective study.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: July 13, 2024

Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary.

Role of fertility-sparing surgery and further prognostic factors in borderline tumors of the ovary.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: April 16, 2024

Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.

Adult ovarian granulosa cell tumors: analysis of outcomes and risk factors for recurrence.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: February 09, 2023

Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database.

Treatment and survival of patients with malignant ovarian sex cord-stromal cell tumours: An analysis of the Arbeitsgemeinschaft für Gynäkologische Onkologie (AGO) study group CORSETT database.

Journal: Journal of surgical oncology

Published: September 23, 2022

Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.

Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.

Journal: Archives of gynecology and obstetrics

Published: July 20, 2022

Reconstructive Surgery versus Primary Closure following Vulvar Cancer Excision: A Wide Single-Center Experience.

Reconstructive Surgery versus Primary Closure following Vulvar Cancer Excision: A Wide Single-Center Experience.

Journal: Cancers

Published: March 06, 2022

Response evaluation after neoadjuvant therapy: evaluation of chemotherapy response score and serological and/or radiological assessment of response in ovarian cancer patients.

Response evaluation after neoadjuvant therapy: evaluation of chemotherapy response score and serological and/or radiological assessment of response in ovarian cancer patients.

Journal: Archives of gynecology and obstetrics

Published: January 13, 2021

Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer.

Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 10, 2020

Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.

Role of delayed interval debulking for persistent residual disease after more than 5 cycles of chemotherapy for primary advanced ovarian cancer. An international multicenter study.

Journal: Gynecologic oncology

Published: July 19, 2020

Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?

Is the Oncological Outcome of Early Stage Uterine Carcinosarcoma Different from That of Grade 3 Endometrioid Adenocarcinoma?

Journal: Oncology research and treatment

Published: July 03, 2020

Showing 1-12 of 22

Last Updated: 09/26/2026